review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1396-0296.2004.04038.X |
P698 | PubMed publication ID | 15379770 |
P50 | author | Dafna D. Gladman | Q37605821 |
P433 | issue | 5 | |
P304 | page(s) | 350-363 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Dermatologic Therapy | Q15766374 |
P1476 | title | Psoriatic arthritis | |
P478 | volume | 17 |
Q37142425 | Adalimumab in dermatology |
Q39837952 | Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial |
Q61919074 | Coping with arthritis is experienced as a dynamic balancing process. A qualitative study |
Q36264972 | Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis |
Q36863477 | Developing a diagnostic checklist of traditional Chinese medicine symptoms and signs for psoriasis: a Delphi study |
Q38178202 | Does treatment of psoriasis reduce the risk of cardiovascular disease? |
Q34103030 | Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment |
Q36392352 | Expression and function of junctional adhesion molecule-C in human and experimental arthritis |
Q42326323 | Functional role of IL-22 in psoriatic arthritis |
Q37987473 | Inflammation, atherosclerosis, and psoriasis. |
Q36821988 | Mechanisms of action of etanercept in psoriasis |
Q34266151 | Obesity, waist circumference, weight change and the risk of psoriasis in US women |
Q48920916 | Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts |
Q85203078 | Recognizing psoriatic arthritis in the dermatology clinic |
Q47586258 | Validation of the Toronto Psoriatic Arthritis Screen II (TOPAS II) questionnaire in a Turkish population |
Q33750434 | Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire |
Search more.